Organic Active Ingredients TRIZ Cases

Fagopyrum dibotyo extract and flavonoid dimers inhibit viral entry into intestinal epithelial cells, addressing the lack of norovirus antivirals.

Diluting honey to 2-50% w/w reduces viscosity and stinging sensation, resolving the contradiction between ease of administration and product stability.

Converts THCA-A to Δ9-THC through staged heating, then extracts the compound using pressurized liquid bonding to eliminate toxic solvent risks.

A topical ointment containing a specific JAK inhibitor compound promotes hair regrowth in alopecia areata patients.

Benzothiadiazepine derivatives address limited efficacy of existing compounds by enhancing pharmacological activity through specific structural modifications.

Replacing alpha-tocopherol with beta, gamma, and delta isoforms enhances oligosaccharide assimilation efficiency by bifidobacteria.

Antisense polynucleotide agents bind to PNPLA3 mRNA to inhibit gene expression and reduce triglyceride accumulation in the liver.

Optimized glass composition prevents particulate shedding in pharmaceutical solutions while maintaining chemical stability.

Galactose-modified dextran sulfate binds blood LDL and directs the complex to hepatocytes for decomposition, avoiding invasive apheresis procedures.

Heterocyclic derivatives selectively block Nav1.7 and Nav1.8 channels to treat pain while avoiding cardiac side effects from Nav1.5 inhibition.

Pyrazole derivatives with tailored substituents target TAAR1 receptors, reducing side effects from adrenergic binding.

Targeting PLA2G5 reduces intravascular hemolysis severity, preventing lipid dysbiosis and lowering mortality associated with sepsis.

Formula I fused bicyclic compounds inhibit MET, ALK, and RON kinases to treat cancers while maintaining oral bioavailability.

Abl kinase inhibitors reduce axon overgrowth by targeting Dscam pathways, improving therapeutic effectiveness while minimizing cancer risk.

Combining sebacoyl dinalbuphine with acetaminophen creates a synergistic analgesic formulation.

Demethylating agents reverse hypermethylation of effector gene promoters to restore cytokine production and cytotoxic activity during chronic antigen exposure.

Nicotine and pilocarpine compositions reduce oral cancer risk by managing withdrawal symptoms without triggering nicotinic receptors.

Modular isoquinoline compounds inhibit Wnt signaling and DYRK1A to treat disorders with aberrant cellular proliferation.

Radical coupling of flavonoids in mild aqueous media eliminates toxic heavy metal catalysts while enabling high-yield synthesis.

Micronized Compound A with D90 ≤ 20 µm inhibits FGFR1 and KDR to overcome chemotherapy resistance in advanced neuroendocrine tumors.

A pharmaceutical composition containing poly-gamma-glutamic acid and aspartame stimulates the immune system to treat cervical intraepithelial neoplasia.

Hydrogel entrapping solid lipid matrix particles releases local anesthetics in a biphasic manner for sustained surgical analgesia.

Dual-layer nalbuphine tablets combine immediate and sustained release to maintain therapeutic blood levels while reducing dosing frequency.

Strategic high dose vitamin D regimens reduce pulmonary inflammation and mean pulmonary artery pressure while accelerating epithelial tissue regeneration.

An oral care composition alters biofilm composition to reduce harmful microorganisms while increasing health-promoting species.

Aqueous extraction isolates specific glucuronide compounds from Glechoma longituba to inhibit DPP4 enzyme activity, reducing blood glucose levels.

A methacrylic resin ink composition reduces offset and sticking in printing.

Monitoring pERK expression levels guides naltrexone dosage adjustments, resolving the trade-off between therapeutic efficacy and immune suppression.

6-Azaindole compounds inhibit Toll-like receptor 7, 8, and 9 signaling to treat autoimmune diseases with improved stability.

A STAT5 antagonist downregulates HIF 2a to eliminate residual cancer stem cells after initial tyrosine kinase inhibitor treatment.

Merges IAP inhibitors with immune checkpoint modulators to overcome drug resistance and inhibit metastasis.

A marine algal glycoprotein medicament treats fatty liver, hepatitis, and cirrhosis.

T151742 aurone derivatives specifically inhibit ERO1α activity, addressing resistance in non-small cell lung cancer treatments.

Replacing phenylsulfonamide groups with sulfoximines eliminates carbonic anhydrase inhibition side effects while maintaining potent tumor growth suppression.

Cepharanthine blocks the HLA-DR3 antigen binding pocket, preventing autoimmune attacks on pancreatic beta cells while minimizing global immune suppression.

GHSR1a antagonists block ghrelin signaling to reduce proteasome-mediated muscle degradation and improve endurance in sarcopenia.

Bifunctional compounds recruit the ubiquitin/proteasome system to degrade target enzymes.

Segmentation and local quality principles guide the design of a specific siRNA precursor that inhibits K-RAS expression to treat resistant tumors.

Novel 2,3-dihydro-furo[2,3-c]pyridine derivatives activate GPR119 receptors to stimulate insulin secretion and improve beta cell function.

Buchwald cross-coupling replaces hydrazine to synthesize the triazolopyrimidine gamma-secretase modulator without column purification.

A tiotropium metered dose inhaler composition uses a silane primer and fluorinated canister lining to prevent drug adsorption.

A Chk-1 inhibitor synthesis route uses crystalline intermediates to replace chromatography and reduce reaction steps.

Modified purine nucleotides overcome toxicity and mutation risks by acting as intermediaries that inhibit viral replication.

Segmented biodegradable polymer matrices release paclitaxel gradually to maintain effective vessel wall concentrations, reducing systemic dosage requirements.

Simultaneous inhibition of GST-π and RB1CC1 enhances apoptosis while reducing side effects from normal cell suppression.

Segmenting hydrophilic polymers into low and high molecular weight components resolves the contradiction between rapid API release and abuse deterrent strength.

Leucine replaces phospholipids to maintain dispersibility while improving chemical stability against moisture.